158 related articles for article (PubMed ID: 10691185)
1. Molecular composition of progenitor toxin produced by Clostridium botulinum type C strain 6813.
Watanabe T; Sagane Y; Kouguchi H; Sunagawa H; Inoue K; Fujinaga Y; Oguma K; Ohyama T
J Protein Chem; 1999 Oct; 18(7):753-60. PubMed ID: 10691185
[TBL] [Abstract][Full Text] [Related]
2. Characterization of nicking of the nontoxic-nonhemagglutinin components of Clostridium botulinum types C and D progenitor toxin.
Sagane Y; Watanabe T; Kouguchi H; Sunagawa H; Inoue K; Fujinaga Y; Oguma K; Ohyama T
J Protein Chem; 2000 Oct; 19(7):575-81. PubMed ID: 11233171
[TBL] [Abstract][Full Text] [Related]
3. Molecular composition of Clostridium botulinum type A progenitor toxins.
Inoue K; Fujinaga Y; Watanabe T; Ohyama T; Takeshi K; Moriishi K; Nakajima H; Inoue K; Oguma K
Infect Immun; 1996 May; 64(5):1589-94. PubMed ID: 8613365
[TBL] [Abstract][Full Text] [Related]
4. Characterization of nontoxic-nonhemagglutinin component of the two types of progenitor toxin (M and L) produced by Clostridium botulinum type D CB-16.
Ohyama T; Watanabe T; Fujinaga Y; Inoue K; Sunagawa H; Fujii N; Inoue K; Oguma K
Microbiol Immunol; 1995; 39(7):457-65. PubMed ID: 8569530
[TBL] [Abstract][Full Text] [Related]
5. Characterization and reconstitution of functional hemagglutinin of the Clostridium botulinum type C progenitor toxin.
Kouguchi H; Watanabe T; Sagane Y; Ohyama T
Eur J Biochem; 2001 Jul; 268(14):4019-26. PubMed ID: 11453996
[TBL] [Abstract][Full Text] [Related]
6. Molecular construction of Clostridium botulinum type C progenitor toxin and its gene organization.
Fujinaga Y; Inoue K; Shimazaki S; Tomochika K; Tsuzuki K; Fujii N; Watanabe T; Ohyama T; Takeshi K; Inoue K
Biochem Biophys Res Commun; 1994 Dec; 205(2):1291-8. PubMed ID: 7802661
[TBL] [Abstract][Full Text] [Related]
7. Molecular composition of the 16S toxin produced by a Clostridium botulinum type D strain, 1873.
Nakajima H; Inoue K; Ikeda T; Fujinaga Y; Sunagawa H; Takeshi K; Ohyama T; Watanabe T; Inoue K; Oguma K
Microbiol Immunol; 1998; 42(9):599-605. PubMed ID: 9802560
[TBL] [Abstract][Full Text] [Related]
8. Dichain structure of botulinum neurotoxin: identification of cleavage sites in types C, D, and F neurotoxin molecules.
Sagane Y; Watanabe T; Kouguchi H; Sunagawa H; Inoue K; Fujinaga Y; Oguma K; Ohyama T
J Protein Chem; 1999 Nov; 18(8):885-92. PubMed ID: 10839626
[TBL] [Abstract][Full Text] [Related]
9. Characterization of toxin complex produced by a unique strain of Clostridium botulinum serotype D 4947.
Hasegawa K; Watanabe T; Sato H; Sagane Y; Mutoh S; Suzuki T; Yamano A; Kouguchi H; Takeshi K; Kamaguchi A; Fujinaga Y; Oguma K; Ohyama T
Protein J; 2004 Aug; 23(6):371-8. PubMed ID: 15517984
[TBL] [Abstract][Full Text] [Related]
10. The complete amino acid sequence of the Clostridium botulinum type D neurotoxin, deduced by nucleotide sequence analysis of the encoding phage d-16 phi genome.
Sunagawa H; Ohyama T; Watanabe T; Inoue K
J Vet Med Sci; 1992 Oct; 54(5):905-13. PubMed ID: 1420572
[TBL] [Abstract][Full Text] [Related]
11. In vitro reconstitution of the Clostridium botulinum type D progenitor toxin.
Kouguchi H; Watanabe T; Sagane Y; Sunagawa H; Ohyama T
J Biol Chem; 2002 Jan; 277(4):2650-6. PubMed ID: 11713244
[TBL] [Abstract][Full Text] [Related]
12. [Structure and function of botulinum toxin].
Fujii N
Hokkaido Igaku Zasshi; 1995 Jan; 70(1):19-28. PubMed ID: 7744367
[TBL] [Abstract][Full Text] [Related]
13. Complete subunit structure of the Clostridium botulinum type D toxin complex via intermediate assembly with nontoxic components.
Mutoh S; Kouguchi H; Sagane Y; Suzuki T; Hasegawa K; Watanabe T; Ohyama T
Biochemistry; 2003 Sep; 42(37):10991-7. PubMed ID: 12974634
[TBL] [Abstract][Full Text] [Related]
14. Role of C-terminal region of HA-33 component of botulinum toxin in hemagglutination.
Sagane Y; Kouguchi H; Watanabe T; Sunagawa H; Inoue K; Fujinaga Y; Oguma K; Ohyama T
Biochem Biophys Res Commun; 2001 Nov; 288(3):650-7. PubMed ID: 11676492
[TBL] [Abstract][Full Text] [Related]
15. Four molecules of the 33 kDa haemagglutinin component of the Clostridium botulinum serotype C and D toxin complexes are required to aggregate erythrocytes.
Mutoh S; Suzuki T; Hasegawa K; Nakazawa Y; Kouguchi H; Sagane Y; Niwa K; Watanabe T; Ohyama T
Microbiology (Reading); 2005 Dec; 151(Pt 12):3847-3858. PubMed ID: 16339931
[TBL] [Abstract][Full Text] [Related]
16. Molecular diversity of neurotoxins from Clostridium botulinum type D strains.
Moriishi K; Syuto B; Kubo S; Oguma K
Infect Immun; 1989 Sep; 57(9):2886-91. PubMed ID: 2668193
[TBL] [Abstract][Full Text] [Related]
17. C. botulinum neurotoxin types A and E: isolated light chain breaks down into two fragments. Comparison of their amino acid sequences with tetanus neurotoxin.
DasGupta BR; Foley J
Biochimie; 1989; 71(11-12):1193-200. PubMed ID: 2517479
[TBL] [Abstract][Full Text] [Related]
18. Spontaneous nicking in the nontoxic-nonhemagglutinin component of the Clostridium botulinum toxin complex.
Sagane Y; Watanabe T; Kouguchi H; Sunagawa H; Obata S; Oguma K; Ohyama T
Biochem Biophys Res Commun; 2002 Mar; 292(2):434-40. PubMed ID: 11906181
[TBL] [Abstract][Full Text] [Related]
19. Immunological characterization of the neurotoxin produced by Clostridium botulinum type A associated with infant botulism in Japan.
Kozaki S; Nakaue S; Kamata Y
Microbiol Immunol; 1995; 39(10):767-74. PubMed ID: 8577267
[TBL] [Abstract][Full Text] [Related]
20. Molecular characterization of two forms of nontoxic-nonhemagglutinin components of Clostridium botulinum type A progenitor toxins.
Fujita R; Fujinaga Y; Inoue K; Nakajima H; Kumon H; Oguma K
FEBS Lett; 1995 Nov; 376(1-2):41-4. PubMed ID: 8521962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
